ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

First-in-human, pharmacokinetic and pharmacodynamic phase I study of Resminostat, an oral histone deacetylase inhibitor, in patients with advanced solid tumors.

André T Brunetto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.